| Pfizer AG - Xalkori 50 mg, filmüberzogenes Granulat zum Einnehmen | | 69467 | | 02 | | Xalkori 50 mg | | filmüberzogenes Granulat zum Einnehmen | | L01ED01 | | | | 29.08.2024 | | |
| | Composition | | crizotinibum 50 mg, alcohol stearylicus, poloxamerum 407, saccharum 14.29 mg, talcum, hypromellosum, macrogolum 4000, glyceroli mono/dipalmitas/stearas/oleas, triglycerida media, ad granulatum pro dosi. | | Packungsbestandteile | | | | | | | | | Inactive agents | Dose |
|---|
| | | | | | | | | | Hypromellosum | | | Macrogol | 4000 | | Poloxamer | 407 | | Saccharum | 14.29 mg | | Talcum | | | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 60 | PR | PR | A | | No |
|
|
